
TSBioAdvisors TS BioAdvisors (TSBA) provides tailored global commercial, marketing and market access strategy consulting and fractional commercial leadership to the biopharma industry, with a focus on serving cell and gene therapy (CGT) and rare disease innovators. Our mission is to help our clients craft and execute insights-driven global commercialization, market access, value demonstration and go-to-market strategies that maximize the long-term commercial, strategic partnership and financing potential of their pioneering, high value products. Ted Slocomb, Founder and Managing Partner of TSBA is a former cell and gene therapy commercial leader (VP level roles at Kite Pharma, Astellas Gene Therapies, Audentes Therapeutics) and a past co-chair of the ARM Value and Access Committee. Consulting Firm

TSBioAdvisors

TS BioAdvisors (TSBA) provides tailored global commercial, marketing and market access strategy consulting and fractional commercial leadership to the biopharma industry, with a focus on serving cell and gene therapy (CGT) and rare disease innovators. Our mission is to help our clients craft and execute insights-driven global commercialization, market access, value demonstration and go-to-market strategies that maximize the long-term commercial, strategic partnership and financing potential of their pioneering, high value products. Ted Slocomb, Founder and Managing Partner of TSBA is a former cell and gene therapy commercial leader (VP level roles at Kite Pharma, Astellas Gene Therapies, Audentes Therapeutics) and a past co-chair of the ARM Value and Access Committee.

Consulting Firm